GENEPHARM AMLODIPINE amlodipine 2.5 mg (as besilate) tablet blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

amlodipine besilate, Quantity: 3.5 mg

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

INN (Isem Internazzjonali):

amlodipine besilate

Għamla farmaċewtika:

Tablet, uncoated

Kompożizzjoni:

Excipient Ingredients: lactose monohydrate; magnesium stearate; maize starch; microcrystalline cellulose

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

30 tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Hypertension - Genepharm Amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. Patients not adequately controlled on a single antihypertensive agent may benefit from the addition of Genepharm Amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor. Angina - Genepharm Amlodipine is indicated for the first line treatment of chronic stable angina. Genepharm Amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs.

Sommarju tal-prodott:

Visual Identification: white to off white, round, unscored tablets, engraved "APO" on one side and "AML" over "2.5" on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2007-12-13